Skip to main content
Equibles
STAA logo

STAA · Staar Surgical Co · Metrics

Track STAA — free

Use STAA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research STAA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$21.61 -0.71 (-3.18%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.12B
Shares
50.14M
Volume · Oct 21 338.45K Avg daily vol (3M) 917.84K

STAA metrics

82 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$21.61
Market cap
$1.12B

Price action

20 metrics
Price change (1W)
+3.8%
Price change (30D)
+9.8%
Price change (3M)
-8.0%
Price change (6M)
-10.4%
Price change (YTD)
-3.3%
Price change (1Y)
-11.8%
Trailing year
Price change (5Y)
-82.3%
52-week high
$33.34
52-week low
$16.10
Change from 52-week high
-33.1%
Change from 52-week low
+38.6%
Annualized volatility
56.6%
Annualized volatility (3M)
47.3%
Beta
0.3
RSI (14D)
51.8
Price vs SMA 50
-1.3%
Price vs SMA 200
-5.2%
Avg volume (3M)
941,404
Relative volume
0.7
Average dollar volume
$21.59M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
50.14M

Valuation

12 metrics
P / E (TTM)
279.0
Trailing earnings · reciprocal yield 0.4%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.2×
reciprocal yield 31.0%
P / book
3.0
reciprocal yield 33.3%
FCF yield
-0.6%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
0.3%

Historical valuation

8 metrics
P / E historical average (3Y)
133.7×
reciprocal yield 0.7%
P / E historical average (5Y)
129.8×
reciprocal yield 0.8%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-12

Profitability

9 metrics
Gross margin
76.6%
Operating margin
4.0%
Trailing 12 months
Net margin
1.1%
Gross profit (TTM)
$260.20M
Operating profit (TTM)
$13.73M
Net income (TTM)
$3.84M
Trailing 12 months
Diluted EPS (TTM)
$0.08
FCF margin
-2.0%
Effective tax rate
77.9%

Per share

11 metrics
Revenue per diluted share (TTM)
$6.71
Gross profit per diluted share (TTM)
$5.14
Operating profit per diluted share (TTM)
$0.25
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$0.06
Operating cash flow per diluted share (TTM)
$-0.07
Free cash flow per diluted share (TTM)
$-0.14
Capital expenditures per diluted share (TTM)
$0.07
R&D per diluted share (TTM)
$0.76
Stock compensation per diluted share (TTM)
$0.56
Book value per share
$7.08

Growth

11 metrics
Revenue growth YoY
+111.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$339.59M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+4.0%
Year over year · more shares
Revenue CAGR (3Y)
+0.0%
Revenue CAGR (5Y)
+7.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
1.1%
Return on assets
0.8%
Debt / equity
—
Current ratio
4.7
EBITDA (TTM)
—
Free cash flow (TTM)
−$6.75M
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$181.49M
Latest balance sheet
Cash & equivalents
$148.58M
Total assets
$475.20M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$3.25M
Capital expenditures (TTM)
$3.50M
R&D (TTM)
$38.32M
SG&A (TTM)
$246.47M
Stock compensation (TTM)
$28.15M
R&D / revenue
11.3%
Stock compensation / revenue
8.3%

Ownership (13F)

9 metrics
13F filers
201
13F filer change QoQ
+14
Institutional ownership
111.3%
Conviction holders (share of 13F filers)
3.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+0.5%
Holder tenure
15.5
Price vs estimated holder cost
+17.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
22.7%

Short interest

3 metrics
Short interest
7.5%
Latest settlement · 2.8 days to cover
Days to cover
2.8d
Short-squeeze score
50 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 718937 CUSIP 852312305 13F (30d) 21 filings 21 filers Visit website Investor relations